Lipiodol Injection
NDC 67684-1901
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
Lipiodol (ethiodized oil) is a NDA-approved product labeled by Guerbet Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a injection for intra-arterial; intralymphatic; intrauterine administration. This product entry covers the primary NDC 67684-1901 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
67684-1901
Proprietary Name:
Lipiodol
Non-Proprietary Name: [1]
Ethiodized Oil
Substance Name: [2]
Ethiodized Oil
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Injection
- A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s): [4]
- Intra-arterial - Administration within an artery or arteries.
- Intralymphatic - Administration within the lymph.
- Intrauterine - Administration within the uterus.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
67684
Product Label ID:
FDA Application Number: [6]
NDA009190
Marketing Category: [8]
NDA - A product marketed under an approved New Drug Application.
Marketing Timeline
Start Marketing Date: [9]
03-21-2014
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Structure Chart
Product Details
What is NDC 67684-1901?
The NDC code 67684-1901 is assigned by the FDA to the product Lipiodol. It is commonly known by its generic name, ethiodized oil. This pharmaceutical product is labeled by Guerbet Llc and is currently categorized as listed product. The medication is a injection administered via intra-arterial; intralymphatic; intrauterine route. In terms of distribution, this product is available in 3 different package configurations. The associated package NDC(s) include: 67684-1901-0, 67684-1901-1, 67684-1901-2. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
Lipiodol is an oil-based radio-opaque contrast agent indicated for:hysterosalpingography in adultslymphography in adult and pediatric patientsselective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC)
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- ETHIODIZED OIL 480 mg/mL - Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-I. (From Merck Index, 11th ed)
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ETHIODIZED OIL (UNII: KZW0R0686Q)
- IODINE (UNII: 9679TC07X4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POPPY SEED OIL (UNII: 9G3Z76ES9J)
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
